DR. Babak Bozorgnia, M.D is a clinical cardiac electrophysiology internal medicine in Allentown, PA with 22 years of experience. The provider is a field of special interest within the subspecialty of cardiovascular disease, specialty of Internal Medicine, which involves intricate technical procedures to evaluate heart rhythms and determine appropriate treatment for them. DR. Babak Bozorgnia, M.D NPI is 1790914299. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: TEMPLE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2002
The provider's business location address is:
1250 S CEDAR CREST BLVD
SUITE 300
ALLENTOWN, PA
ZIP 18103-224
Phone: (610) 402-3110
Fax: (610) 402-3112
The NPI 1790914299 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Routine EKG using at least 12 leads including interpretation and report (HCPCS:93000)
- Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report (HCPCS:93280)
- Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report (HCPCS:93010)
- Evaluation, testing and programming adjustment of defibrillator with analysis, review and report (HCPCS:93284)
- Evaluation, testing and programming adjustment of defibrillator with analysis, review and report (HCPCS:93283)
- Insertion of new or replacement of permanent pacemaker including upper and lower chamber electrodes (HCPCS:33208)
The enumeration date for this NPI number is 7/7/2009 and was last updated on 10/29/2018.